Search

Chau N. Nguyen

Examiner (ID: 8169, Phone: (571)272-1980 , Office: P/2847 )

Most Active Art Unit
2831
Art Unit(s)
2109, 2835, 2841, 2831, 2847, 3621, 2950
Total Applications
2929
Issued Applications
2020
Pending Applications
223
Abandoned Applications
739

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4745301 [patent_doc_number] => 20080089903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES' [patent_app_type] => utility [patent_app_number] => 11/837953 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4461 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089903.pdf [firstpage_image] =>[orig_patent_app_number] => 11837953 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/837953
CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES Aug 12, 2007 Abandoned
Array ( [id] => 5271601 [patent_doc_number] => 20090075377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'MOLECULAR INTERACTIONS IN CELLS' [patent_app_type] => utility [patent_app_number] => 11/833848 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 59941 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075377.pdf [firstpage_image] =>[orig_patent_app_number] => 11833848 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/833848
MOLECULAR INTERACTIONS IN CELLS Aug 2, 2007 Abandoned
Array ( [id] => 6070087 [patent_doc_number] => 20110044937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY' [patent_app_type] => utility [patent_app_number] => 12/375361 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14546 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044937.pdf [firstpage_image] =>[orig_patent_app_number] => 12375361 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375361
STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY Jul 26, 2007 Abandoned
Array ( [id] => 4797436 [patent_doc_number] => 20080009022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Immunization of dairy cattle with chimeric gapC protein against streptococcus infection' [patent_app_type] => utility [patent_app_number] => 11/825796 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 18074 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009022.pdf [firstpage_image] =>[orig_patent_app_number] => 11825796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/825796
Immunization of dairy cattle with chimeric gapC protein against streptococcus infection Jul 8, 2007 Abandoned
Array ( [id] => 4964867 [patent_doc_number] => 20080107687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'FELINE VACCINES AGAINST AVIAN INFLUENZA' [patent_app_type] => utility [patent_app_number] => 11/767276 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28740 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107687.pdf [firstpage_image] =>[orig_patent_app_number] => 11767276 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/767276
FELINE VACCINES AGAINST AVIAN INFLUENZA Jun 21, 2007 Abandoned
Array ( [id] => 5392154 [patent_doc_number] => 20090209467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'VIRAL CAPSID PROTEINS AND ANY PEPTIDES OR COMPOSITIONS THEREOF FOR THE TREATMENT OF PATHOLOGIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/305323 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12445 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209467.pdf [firstpage_image] =>[orig_patent_app_number] => 12305323 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305323
Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders Jun 17, 2007 Issued
Array ( [id] => 4797873 [patent_doc_number] => 20080009459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences' [patent_app_type] => utility [patent_app_number] => 11/818873 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14260 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009459.pdf [firstpage_image] =>[orig_patent_app_number] => 11818873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/818873
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences Jun 14, 2007 Abandoned
Array ( [id] => 4657135 [patent_doc_number] => 20080025996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods and Compositions Comprising Polycationic Compounds' [patent_app_type] => utility [patent_app_number] => 11/757007 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6121 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025996.pdf [firstpage_image] =>[orig_patent_app_number] => 11757007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/757007
Methods and Compositions Comprising Polycationic Compounds May 31, 2007 Abandoned
Array ( [id] => 4670397 [patent_doc_number] => 20080045457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Ancestral Hepatitis C virus envelope protein sequence' [patent_app_type] => utility [patent_app_number] => 11/809365 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15831 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045457.pdf [firstpage_image] =>[orig_patent_app_number] => 11809365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/809365
Ancestral Hepatitis C virus envelope protein sequence May 30, 2007 Abandoned
Array ( [id] => 5045600 [patent_doc_number] => 20070264273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/746415 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23818 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264273.pdf [firstpage_image] =>[orig_patent_app_number] => 11746415 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/746415
SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF May 8, 2007 Abandoned
Array ( [id] => 6632718 [patent_doc_number] => 20100173387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/298583 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18222 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173387.pdf [firstpage_image] =>[orig_patent_app_number] => 12298583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/298583
METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR Apr 26, 2007 Abandoned
Array ( [id] => 6302436 [patent_doc_number] => 20100068224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Method for Producing Viral Vaccine and Therapeutic Peptide Antigens' [patent_app_type] => utility [patent_app_number] => 12/297162 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22241 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068224.pdf [firstpage_image] =>[orig_patent_app_number] => 12297162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/297162
Method for Producing Viral Vaccine and Therapeutic Peptide Antigens Apr 23, 2007 Abandoned
Array ( [id] => 174001 [patent_doc_number] => 07659380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Method of isolation and purification of trypsin from pronase protease and use thereof' [patent_app_type] => utility [patent_app_number] => 11/788714 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9420 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659380.pdf [firstpage_image] =>[orig_patent_app_number] => 11788714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/788714
Method of isolation and purification of trypsin from pronase protease and use thereof Apr 19, 2007 Issued
Array ( [id] => 4669373 [patent_doc_number] => 20080044433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Epitopes of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/786414 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15155 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044433.pdf [firstpage_image] =>[orig_patent_app_number] => 11786414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/786414
Epitopes of hepatitis C virus Apr 9, 2007 Abandoned
Array ( [id] => 5199092 [patent_doc_number] => 20070298410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Assay to detect HCV receptor binding' [patent_app_type] => utility [patent_app_number] => 11/784521 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5962 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298410.pdf [firstpage_image] =>[orig_patent_app_number] => 11784521 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/784521
Assay to detect HCV receptor binding Apr 5, 2007 Abandoned
Array ( [id] => 6451006 [patent_doc_number] => 20100280268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/293589 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35410 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280268.pdf [firstpage_image] =>[orig_patent_app_number] => 12293589 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/293589
HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM Apr 5, 2007 Abandoned
Array ( [id] => 4803550 [patent_doc_number] => 20080015139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Soluble virus-specific T-cell receptor compositions' [patent_app_type] => utility [patent_app_number] => 11/784277 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4464 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015139.pdf [firstpage_image] =>[orig_patent_app_number] => 11784277 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/784277
Soluble virus-specific T-cell receptor compositions Apr 4, 2007 Abandoned
Array ( [id] => 4681816 [patent_doc_number] => 20080248042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc' [patent_app_type] => utility [patent_app_number] => 11/783297 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7810 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248042.pdf [firstpage_image] =>[orig_patent_app_number] => 11783297 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/783297
Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc Apr 4, 2007 Abandoned
Array ( [id] => 7511667 [patent_doc_number] => 20110257377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Covalently linked complexes of HIV TAT and ENV PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/225655 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15046 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257377.pdf [firstpage_image] =>[orig_patent_app_number] => 12225655 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225655
Covalently linked complexes of HIV TAT and ENV PROTEINS Mar 26, 2007 Abandoned
Array ( [id] => 4839407 [patent_doc_number] => 20080279892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Recombinant RSV Virus Expression Systems And Vaccines' [patent_app_type] => utility [patent_app_number] => 11/690957 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 34626 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279892.pdf [firstpage_image] =>[orig_patent_app_number] => 11690957 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/690957
Recombinant RSV Virus Expression Systems And Vaccines Mar 25, 2007 Abandoned
Menu